AIMS AND BACKGROUND: The study analyzed survival after malignant mesothelioma in the population-based Registry of Malignant Mesothelioma of Piedmont (NW Italy, 4.5 million total population). It focused on possible differences related to period of diagnosis a proxy of changes in diagnostic or therapeutic procedures. METHODS: Cases were actively searched in pathology units and files of hospital admissions and discharges. In 1990-1998, 693 incident cases were diagnosed in residents in the region: 590 of them had a histologic diagnosis of pleural mesothelioma in life and were included in the study. Vital status was ascertained at the municipality of residence as of January 1, 2000. RESULTS: Fifty-eight cases were alive (9.8%) and 20 were ...
Background:Asbestos-related malignant pleural mesothelioma is one of the most lethal tumor types. Th...
View at Publisher|Ask by NILDE(opens in a new window)| Export | Download | Add to List | More....
OBJECTIVES: Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer, for which treatmen...
AIMS AND BACKGROUND: The study analyzed survival after malignant mesothelioma in the population-base...
Background: Pleural mesothelioma (PM) is a rare, highly lethal tumor. A definite consensus on its ma...
Introduction:This study characterizes the overall survival (OS) and variables affecting OS in patien...
Background: Malignant pleural mesothelioma (MPM) is a rare cancer with a poor prognosis. Centralizat...
Malignant mesothelioma (MM) of the pleura or peritoneum is a universally fatal disease attracting an...
OBJECTIVE: Treatment of malignant pleural mesothelioma (MPM) remains disappointing, although recent ...
Background: There has been an evolving role of surgery for malignant pleural mesothelioma (MPM) over...
Introduction: Malignant mesothelioma (MM) is an aggressive cancer that primarily arises from the ple...
Malignant pleural mesothelioma (MPM) is a relatively rare, but aggressive tumor that causes high mor...
BACKGROUND: It is important to regularly update survival estimates of patients with malignant mesoth...
© 2015 Public Health Association of Australia. Introduction: Malignant pleural mesothelioma (MPM) an...
AbstractSurvival for mesothelioma has been shown to be poor, with marginal improvement over time. Re...
Background:Asbestos-related malignant pleural mesothelioma is one of the most lethal tumor types. Th...
View at Publisher|Ask by NILDE(opens in a new window)| Export | Download | Add to List | More....
OBJECTIVES: Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer, for which treatmen...
AIMS AND BACKGROUND: The study analyzed survival after malignant mesothelioma in the population-base...
Background: Pleural mesothelioma (PM) is a rare, highly lethal tumor. A definite consensus on its ma...
Introduction:This study characterizes the overall survival (OS) and variables affecting OS in patien...
Background: Malignant pleural mesothelioma (MPM) is a rare cancer with a poor prognosis. Centralizat...
Malignant mesothelioma (MM) of the pleura or peritoneum is a universally fatal disease attracting an...
OBJECTIVE: Treatment of malignant pleural mesothelioma (MPM) remains disappointing, although recent ...
Background: There has been an evolving role of surgery for malignant pleural mesothelioma (MPM) over...
Introduction: Malignant mesothelioma (MM) is an aggressive cancer that primarily arises from the ple...
Malignant pleural mesothelioma (MPM) is a relatively rare, but aggressive tumor that causes high mor...
BACKGROUND: It is important to regularly update survival estimates of patients with malignant mesoth...
© 2015 Public Health Association of Australia. Introduction: Malignant pleural mesothelioma (MPM) an...
AbstractSurvival for mesothelioma has been shown to be poor, with marginal improvement over time. Re...
Background:Asbestos-related malignant pleural mesothelioma is one of the most lethal tumor types. Th...
View at Publisher|Ask by NILDE(opens in a new window)| Export | Download | Add to List | More....
OBJECTIVES: Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer, for which treatmen...